Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab
贝伐珠单抗治疗复发性增强型IDH突变型胶质瘤的临床和影像学预后因素
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdag089
Le, Collin T; Sanvito, Francesco; Yang, Chuyin; Eldred, Blaine S C; Raymond, Catalina; Prins, Terry J; Fisher, Addison; Li, Tie; Liau, Linda M; Chong, Robert A; Nghiemphu, Phioanh Leia; Cloughesy, Timothy F; Lai, Albert; Ellingson, Benjamin M